Skip to main content

Table 1 Characteristics of the patients with clinical N1 non-small cell lung cancer

From: Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study

  Number
Sex
 Male 46
 Female 14
Age (years)
 Median 70
 Range 32–81
Histological type
 Adenocarcinoma 27
 Squamous cell carcinoma 27
 Pleomorphic carcinoma 3
 Adenosquamous cell carcinoma 2
 Large cell carcinoma 1
Size of primary tumor (mm)
 Median 35
 Range 13–88
Clinical T status
 T1 16
 T2 29
 T3 14
 T4 1
CEA (ng/mL)
 Median 4.8
 Range 1.5–152.2
SCC (ng/mL)
 Median 0.8
 Range 0.0–19.7
CYFRA (ng/mL)
 Median 2.48
 Range 0.59–53.08
FDG-PET
 Number of patients 35
 Median of SUVmax 6
 Range of SUVmax 0–22.78
FDG-PET/CT
 Number of patients 25
 Median of SUVmax 11.45
 Range of SUVmax 1.90–52.60
Surgical approach
 VATS 23
 Thoracotomy 20
 Conversion (VATS to thoracotomy) 17
Operative procedure
 Pneumonectomy 7
 Lobectomy 51
  + bronchoplasty 3
  + angioplasty 1
  + bronchoplasty & angioplasty 2
 Segmentectomy 2
Pathological T status
 pT1 15
 pT2 29
 pT3 14
 pT4 2
Pathological N status
 pN0 23
 pN1 22
 pN2 15
Pathological stage
 IA 4
 IB 12
 IIA 14
 IIB 6
 IIIA 23
 IIIB 1